Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Sales Growth

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Sales Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Net Sales Growth(%) 17.452.0918.850.506.06

What is the latest Net Sales Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Sales Growth ratio of SYNCOM FORMULATIONS (INDIA) is 17.45 based on Mar2024 Consolidated results.
Year Net Sales Growth
Mar202417.45
Mar20232.09
Mar202218.85
Mar20170.50
Mar20166.06

How is Net Sales Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Sales Growth % Change
Mar2024 17.45
734.93
Mar2023 2.09
-88.91
Mar2022 18.85
3,670.00
Mar2017 0.5
-91.75
Mar2016 6.06 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Net Sales Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,951.4 Cr -4.8% 34.2% 76.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.8%

34.2%

76.8%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses